JOANA VANESSA GONZÁLEZ REYES

Universidad Autónoma de Querétaro. Facultad de Enfermería. Licenciatura en enfermería. Farmacología II. “Vídeo Metformina”. 07-03-2019. Joana Vanessa González Reyes

Bibliografía

1.  Búsqueda | Portal Regional de la BVS [Internet]. [citado 31 de enero de 2019]. Disponible en: http://pesquisa.bvsalud.org/portal/decs-locator/?lang=es&tree_id=D27.505.954&term=D27.505.954&tree_id=D02.078.370.141.450&term=D02.078.370.141.450

2.  Graham GG, Punt J, Arora M, Day RO, Doogue MP, Duong JK, et al. Clinical pharmacokinetics of metformin. Clin Pharmacokinet. febrero de 2011;50(2):81-98.

3.  Chan P, Shao L, Tomlinson B, Zhang Y, Liu Z-M. Metformin transporter pharmacogenomics: insights into drug disposition-where are we now? Expert Opin Drug Metab Toxicol. noviembre de 2018;14(11):1149-59.

4.  Wandee J, Prawan A, Senggunprai L, Kongpetch S, Kukongviriyapan V. Metformin sensitizes cholangiocarcinoma cell to cisplatin-induced cytotoxicity through oxidative stress mediated mitochondrial pathway. Life Sci. 15 de enero de 2019;217:155-63.

5.  Chan P, Shao L, Tomlinson B, Zhang Y, Liu Z-M. Metformin transporter pharmacogenomics: insights into drug disposition-where are we now? Expert Opin Drug Metab Toxicol. noviembre de 2018;14(11):1149-59.

6.  Tong D, Liu Q, Liu G, Xu J, Lan W, Jiang Y, et al. Metformin inhibits castration-induced EMT in prostate cancer by repressing COX2/PGE2/STAT3 axis. Cancer Lett. 28 de 2017;389:23-32.

7.  Grandone A, Di Sessa A, Umano GR, Toraldo R, Miraglia Del Giudice E. New treatment modalities for obesity. Best Pract Res Clin Endocrinol Metab. 2018;32(4):535-49.

8.  Jesus C, Jesus I, Agius M. A review of the evidence for the use of metformin in the treatment of metabolic syndrome caused by antipsychotics. Psychiatr Danub. septiembre de 2015;27 Suppl 1:S489-491.